In vitro profiling and functional assessments of the anti-diabetic capacity of phenolic-rich extracts of Bulbine natalensis and Bulbine frutescens

Diabet Med. 2023 Feb;40(2):e14770. doi: 10.1111/dme.14770. Epub 2021 Dec 29.

Abstract

Aims: Bulbine natalensis (BN) and Bulbine frutescens (BF) are recommended in South African traditional medicine to treat diabetes, but their modes of action are unknown. This study assessed the phenolic acid profiles, mineral composition and in vitro functional effects of BN and BF to better understand their glucose-lowering capabilities.

Methods: Phenolic acid and mineral composition of BN and BF methanolic extracts were determined by HPLC and inductively coupled plasma optical emission spectroscopy respectively. Antioxidant capacity was assessed by potassium ferricyanide reducing power and 2,2-diphenyl-2-picrylhydrazyl radical scavenging assays, and inhibition of alpha-amylase, alpha-glucosidase, pancreatic lipase and DPP4 was evaluated by standard enzyme assays. The effects of BN and BF extracts on insulin secretion were investigated using static incubations of isolated mouse islets and molecular docking analysis was used to identify interactions of BN and BF with partners that could mediate stimulatory effects on insulin secretion.

Results: Methanolic extracts of BN and BF contained high concentrations of protocatechuic and gallic acids, and high levels of Zn, Mn and Cr. The extracts inhibited alpha-glucosidase, alpha-amylase, pancreatic lipase and DPP4 activities, and they also inhibited free radical generation. Both extracts significantly potentiated glucose-stimulated insulin secretion without significantly affecting basal insulin secretion or islet cell viability. Protocatechuic acid, the most abundant phenolic acid in the extracts, showed high affinity for PKA, PKC, DPP4 and CaMK II in the docking analysis.

Conclusions: BN and BF have multiple beneficial effects on glucoregulatory pathways and they, or their derivatives, could be developed to treat type 2 diabetes.

Keywords: glucoregulatory enzymes; insulin secretion; minerals; molecular docking; phenolic acids; plant extracts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / chemistry
  • Antioxidants / pharmacology
  • Asphodelaceae*
  • Diabetes Mellitus, Type 2* / metabolism
  • Dipeptidyl Peptidase 4
  • Glucose
  • Glycoside Hydrolase Inhibitors
  • Lipase
  • Mice
  • Molecular Docking Simulation
  • Phenols / pharmacology
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology
  • alpha-Amylases
  • alpha-Glucosidases / metabolism

Substances

  • phenolic acid
  • Plant Extracts
  • Glycoside Hydrolase Inhibitors
  • alpha-Glucosidases
  • Dipeptidyl Peptidase 4
  • Phenols
  • alpha-Amylases
  • Antioxidants
  • Lipase
  • Glucose